Jpmorgan Chase & CO ALNYLAM PHARMACEUTICALS INC Transaction History

Jpmorgan Chase & CO

  • $1.22 Trillion
  • Q3 2024
Number of Shares
3,250,000
Previous 6,877,000 52.74%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024
SELL
N/A
-3,627,000 Reduced 52.74%
3,250,000 $0
Q2 2024

Aug 12, 2024
BUY
N/A
5,702,000 Added 485.28%
6,877,000 $0
Q1 2024

May 10, 2024
BUY
N/A
1,060,000 Added 921.74%
1,175,000 $0
Q4 2023

Feb 12, 2024
SELL
N/A
-415,000 Reduced 78.3%
115,000 $0
Q3 2023

Nov 14, 2023
BUY
N/A
530,000 New
530,000 $0
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email